These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2648691

  • 1. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 2. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 3. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Feb; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 4. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 5. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 6. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 7. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 15; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 8. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA, de la Haye R, Rettig K, Kuntz G.
    Vasa; 1992 Nov 30; 21(4):392-402. PubMed ID: 1485475
    [Abstract] [Full Text] [Related]

  • 10. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT, Nicolaides AN, Wolfe JH, Stansby G.
    J Vasc Surg; 2000 Apr 30; 31(4):650-61. PubMed ID: 10753272
    [Abstract] [Full Text] [Related]

  • 11. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Apr 30; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 12. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

  • 13. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD000988. PubMed ID: 17943749
    [Abstract] [Full Text] [Related]

  • 14. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 15. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul 15; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M.
    Angiology; 1994 Jul 15; 45(7):647-53. PubMed ID: 8024164
    [Abstract] [Full Text] [Related]

  • 17. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A, Rieger H.
    Med Klin (Munich); 1990 Jan 15; 85(1):1-5. PubMed ID: 2314351
    [Abstract] [Full Text] [Related]

  • 18. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD000988. PubMed ID: 18253982
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Jan 23; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 20. Buflomedil for intermittent claudication.
    de Backer TL, Vander Stichele R.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD000988. PubMed ID: 23543509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.